{"id":"https://openalex.org/W1999656775","doi":"https://doi.org/10.1002/syn.10144","title":"Opioid peptide receptor studies. 16. Chronic morphine alters G\u2010protein function in cells expressing the cloned mu opioid receptor","display_name":"Opioid peptide receptor studies. 16. Chronic morphine alters G\u2010protein function in cells expressing the cloned mu opioid receptor","publication_year":2002,"publication_date":"2002-10-21","ids":{"openalex":"https://openalex.org/W1999656775","doi":"https://doi.org/10.1002/syn.10144","mag":"1999656775","pmid":"https://pubmed.ncbi.nlm.nih.gov/12422367"},"language":"en","primary_location":{"id":"doi:10.1002/syn.10144","doi":"https://doi.org/10.1002/syn.10144","is_oa":false,"landing_page_url":"https://doi.org/10.1002/syn.10144","pdf_url":null,"source":{"id":"https://openalex.org/S158211696","display_name":"Synapse","issn_l":"0887-4476","issn":["0887-4476","1098-2396"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synapse","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103501601","display_name":"Heng Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heng Xu","raw_affiliation_strings":["Clinical Psychopharmacology Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland 21224, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Psychopharmacology Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland 21224, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047077710","display_name":"Yifeng Lu","orcid":"https://orcid.org/0000-0002-6913-6737","observed_orcids":["https://orcid.org/0000-0002-6913-6737"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yi\u2010Feng Lu","raw_affiliation_strings":["Clinical Psychopharmacology Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland 21224"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Psychopharmacology Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland 21224","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103446078","display_name":"Richard B. Rothman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Richard B. Rothman","raw_affiliation_strings":["Clinical Psychopharmacology Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland 21224"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Psychopharmacology Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland 21224","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5103446078"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"],"apc_list":{"value":3570,"currency":"USD","value_usd":3570},"apc_paid":null,"fwci":0.4634,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.58651033,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"47","issue":"1","first_page":"1","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.7792999744415283,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.7792999744415283,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.21449999511241913,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mu-opioid-receptor","display_name":"mu-opioid receptor","score":0.9679999947547913},{"id":"https://openalex.org/keywords/chronic-morphine","display_name":"chronic morphine","score":0.796999990940094},{"id":"https://openalex.org/keywords/morphine-tolerance","display_name":"morphine tolerance","score":0.9319999814033508},{"id":"https://openalex.org/keywords/g-protein-uncoupling","display_name":"G protein uncoupling","score":0.871999979019165},{"id":"https://openalex.org/keywords/gtpgammas-binding","display_name":"GTPgammaS binding","score":0.8560000061988831},{"id":"https://openalex.org/keywords/camp-signaling","display_name":"cAMP signaling","score":0.656000018119812},{"id":"https://openalex.org/keywords/damgo","display_name":"DAMGO","score":0.6779999732971191},{"id":"https://openalex.org/keywords/receptor-g-protein-coupling","display_name":"receptor-G protein coupling","score":0.5979999899864197},{"id":"https://openalex.org/keywords/binding-site-analysis","display_name":"binding site analysis","score":0.48100000619888306},{"id":"https://openalex.org/keywords/receptor-mutants","display_name":"receptor mutants","score":0.4390000104904175},{"id":"https://openalex.org/keywords/cho-cells","display_name":"CHO cells","score":0.4000000059604645}],"concepts":[{"id":"https://openalex.org/C175656101","wikidata":"https://www.wikidata.org/wiki/Q56646","display_name":"Chinese hamster ovary cell","level":3,"score":0.7251463532447815},{"id":"https://openalex.org/C2776401185","wikidata":"https://www.wikidata.org/wiki/Q5204254","display_name":"DAMGO","level":5,"score":0.6870639324188232},{"id":"https://openalex.org/C14397066","wikidata":"https://www.wikidata.org/wiki/Q14911924","display_name":"\u03bc-opioid receptor","level":4,"score":0.6611056327819824},{"id":"https://openalex.org/C80631254","wikidata":"https://www.wikidata.org/wiki/Q407438","display_name":"G protein","level":3,"score":0.6535094380378723},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.6321879029273987},{"id":"https://openalex.org/C118716","wikidata":"https://www.wikidata.org/wiki/Q5514725","display_name":"GTP'","level":3,"score":0.6205391883850098},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5908453464508057},{"id":"https://openalex.org/C2779276759","wikidata":"https://www.wikidata.org/wiki/Q412747","display_name":"Forskolin","level":3,"score":0.5742952227592468},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5685884356498718},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5469130277633667},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.5018608570098877},{"id":"https://openalex.org/C2779886867","wikidata":"https://www.wikidata.org/wiki/Q421797","display_name":"Opioid receptor","level":4,"score":0.43243318796157837},{"id":"https://openalex.org/C24998067","wikidata":"https://www.wikidata.org/wiki/Q4114622","display_name":"Stimulation","level":2,"score":0.41323503851890564},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3888104557991028},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3868985176086426},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36545759439468384},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3274005055427551},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2634108066558838},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.21246984601020813},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.13166940212249756},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000242","descriptor_name":"Cyclic AMP","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000262","descriptor_name":"Adenylyl Cyclases","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000262","descriptor_name":"Adenylyl Cyclases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005576","descriptor_name":"Colforsin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006224","descriptor_name":"Cricetinae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009020","descriptor_name":"Morphine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013462","descriptor_name":"Sulfur Radioisotopes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016466","descriptor_name":"CHO Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017450","descriptor_name":"Receptors, Opioid, mu","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D017450","descriptor_name":"Receptors, Opioid, mu","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018929","descriptor_name":"Cell Culture Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020536","descriptor_name":"Enzyme Activators","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020875","descriptor_name":"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020962","descriptor_name":"Heterotrimeric GTP-Binding Proteins","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D020962","descriptor_name":"Heterotrimeric GTP-Binding Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/syn.10144","doi":"https://doi.org/10.1002/syn.10144","is_oa":false,"landing_page_url":"https://doi.org/10.1002/syn.10144","pdf_url":null,"source":{"id":"https://openalex.org/S158211696","display_name":"Synapse","issn_l":"0887-4476","issn":["0887-4476","1098-2396"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synapse","raw_type":"journal-article"},{"id":"pmid:12422367","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12422367","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synapse (New York, N.Y.)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.7246000170707703,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1497141468","https://openalex.org/W1544256708","https://openalex.org/W1585650753","https://openalex.org/W1655589213","https://openalex.org/W1886012028","https://openalex.org/W1965816376","https://openalex.org/W1966788282","https://openalex.org/W1968312985","https://openalex.org/W1969783509","https://openalex.org/W1971216816","https://openalex.org/W1972017211","https://openalex.org/W1977462914","https://openalex.org/W1983448091","https://openalex.org/W1986495974","https://openalex.org/W1993477246","https://openalex.org/W2016810487","https://openalex.org/W2035065534","https://openalex.org/W2043587132","https://openalex.org/W2044584217","https://openalex.org/W2045042759","https://openalex.org/W2060366765","https://openalex.org/W2078671315","https://openalex.org/W2085337933","https://openalex.org/W2125850670","https://openalex.org/W2145847623","https://openalex.org/W2172734677","https://openalex.org/W2260577419"],"related_works":["https://openalex.org/W1978445838","https://openalex.org/W2093586204","https://openalex.org/W2149814042","https://openalex.org/W1585650753","https://openalex.org/W2043587132","https://openalex.org/W1989208044","https://openalex.org/W1983448091","https://openalex.org/W2110133277","https://openalex.org/W2004193077","https://openalex.org/W2044584217"],"abstract_inverted_index":{"Chronic":[0],"morphine":[1,48,79,90,129,144,187,205],"treatment":[2,80,158],"results":[3,109],"in":[4,16,175,193,197],"functional":[5],"uncoupling":[6],"of":[7,47,66,74,137,166,204],"the":[8,24,34,89,100,135,138,150,155,160,191,202],"mu":[9,37,180],"opioid":[10,38,181],"receptor":[11,39,182],"and":[12,20,59,63,98,123],"its":[13],"G":[14],"protein":[15],"both":[17],"cell":[18],"culture":[19],"animal":[21],"models.":[22],"In":[23,126,141],"present":[25],"study,":[26],"Chinese":[27],"hamster":[28],"ovary":[29],"(CHO)":[30],"cells":[31,176,199],"stably":[32],"expressing":[33,177],"cloned":[35],"human":[36],"(hMOR-CHO":[40],"cells)":[41],"were":[42,110,172],"incubated":[43],"with":[44,112],"1":[45],"microM":[46],"(or":[49],"no":[50],"drug)":[51],"for":[52,163],"20":[53],"h.":[54],"Subsequently,":[55],"we":[56],"assessed":[57],"DAMGO-":[58],"morphine-stimulated":[60],"[(35)S]-GTP-gamma-S":[61,75,86,119,131,146,194],"binding":[62,120,132,147,195],"agonist-mediated":[64,164],"inhibition":[65,165],"forskolin-stimulated":[67,167],"cAMP":[68,168],"accumulation.":[69,169],"Using":[70],"a":[71,178],"single":[72],"concentration":[73],"(0.05":[76],"nM),":[77],"chronic":[78],"did":[81],"not":[82,173,185],"significantly":[83],"change":[84],"basal":[85],"binding,":[87],"shifted":[88],"EC(50)":[91,161],"from":[92,104,201],"59":[93],"nM":[94],"to":[95,106],"146":[96],"nM,":[97],"decreased":[99],"maximal":[101],"stimulation":[102],"(E(max))":[103],"201%":[105],"177%.":[107],"Similar":[108],"observed":[111,174,196],"DAMGO.":[113],"Binding":[114],"surface":[115],"analysis":[116],"resolved":[117],"two":[118],"sites":[121],"(high-affinity":[122],"low-affinity":[124],"sites).":[125],"control":[127],"cells,":[128,143],"stimulated":[130,145],"by":[133,148],"increasing":[134],"B(max)":[136],"high-affinity":[139,151],"site.":[140],"morphine-treated":[142],"decreasing":[149],"K(d)":[152],"without":[153],"changing":[154],"B(max).":[156],"Morphine":[157],"increased":[159],"(5-11-fold)":[162],"These":[170],"changes":[171,192],"mutant":[179],"which":[183],"does":[184],"develop":[186],"tolerance,":[188],"suggesting":[189],"that":[190],"hMOR-CHO":[198],"result":[200],"development":[203],"tolerance.":[206]},"counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}